A linear steady-state treatment of enzymatic chains. Critique of the crossover theorem and a general procedure to identify interaction sites with an effector.
about
Pyruvate kinase: Function, regulation and role in cancerConstruction of feasible and accurate kinetic models of metabolism: A Bayesian approach.Quantifying global tolerance of biochemical systems: design implications for moiety-transfer cyclesDifferential producibility analysis (DPA) of transcriptomic data with metabolic networks: deconstructing the metabolic response of M. tuberculosisMetabolic consequences of the cytochrome c oxidase deficiency in brain of copper-deficient Mo(vbr) miceIncrease of flux control of cytochrome c oxidase in copper-deficient mottled brindled miceAdvances in network-based metabolic pathway analysis and gene expression data integration.A second mechanism of respiratory control.An integrative approach to understanding microbial diversity: from intracellular mechanisms to community structure.Regulating the cellular economy of supply and demand.Why is uncompetitive inhibition so rare? A possible explanation, with implications for the design of drugs and pesticides.Kinetic responses of β-catenin specify the sites of Wnt control.A kinetic model for RNA-interference of focal adhesions.Constraints on reciprocal flux sensitivities in biochemical reaction networks.Starch: the need for improved quality or quantity--an overview.Metabolic control analysis: a survey of its theoretical and experimental developmentNonparametric dynamic modeling.Global metabolic profiling and its role in systems biology to advance personalized medicine in the 21st century.(13)C MRS and LC-MS Flux Analysis of Tumor Intermediary Metabolism.A topological approach to chemical organizations.Control of respiration by cytochrome c oxidase in intact cells: role of the membrane potentialNetwork dynamics.Bioenergetics and solute transport in lactococci.The role of adenine nucleotide translocators in regulation of oxidative phosphorylation in heart mitochondria.The best models of metabolism.The application of control analysis to helminth pathways.Applications of recombinant DNA technology to studies of metabolic regulationControl by cytochrome c oxidase of the cellular oxidative phosphorylation system depends on the mitochondrial energy state.Unraveling the complex regulatory relationships between metabolism and signal transduction in cancer.First-order kinetics of muscle oxygen consumption, and an equivalent proportionality between QO2 and phosphorylcreatine level. Implications for the control of respiration.Mathematical modelling of the diurnal regulation of the MEP pathway in Arabidopsis.Flux control exerted by overt carnitine palmitoyltransferase over palmitoyl-CoA oxidation and ketogenesis is lower in suckling than in adult rats.Kinetics of metabolic pathways. A system in vitro to study the control of flux.Effects of thyroid hormone on mitochondrial oxidative phosphorylation.Control and inhibition analysis of complex formation processes.ATP binding to cytochrome c diminishes electron flow in the mitochondrial respiratory pathwayThe flux control coefficient of carnitine palmitoyltransferase I on palmitate beta-oxidation in rat hepatocyte cultures.Model of 2,3-bisphosphoglycerate metabolism in the human erythrocyte based on detailed enzyme kinetic equations: computer simulation and metabolic control analysis.Methylerythritol phosphate pathway to isoprenoids: kinetic modeling and in silico enzyme inhibitions in Plasmodium falciparum.Seizure-dependent modulation of mitochondrial oxidative phosphorylation in rat hippocampus.
P2860
Q26798084-E2D268ED-39C3-42D8-9466-FD2C53DC8492Q27329738-15F56E82-1C9E-4FD3-8538-61ACAB9C9099Q28474957-778F11C2-FD98-4C05-9879-ED71ED78AD03Q28478889-18CF0BE1-F81B-4AE2-8C83-1EB44140980CQ28507748-A50B90A4-3045-4BEB-B495-6BF090D2F176Q28592691-365929B6-5909-4A34-A441-A7A196D87ED3Q30777076-54877615-DA21-4A23-9440-BDB360BEAE70Q33601116-293A405A-6DE1-409E-A09E-E47110C523EEQ33615178-3C30D3FF-5D9E-4A51-9371-E9EF6338E33BQ33957106-91631FA2-2D9C-4F3B-B146-61AFC6DCC227Q34050556-61AADDFE-DF5E-44EF-B5E1-F7D8D1D93A6BQ34310708-3E11733A-4394-4774-8B4C-358850A4C139Q34545779-B194DF07-2C73-4264-AA11-CE4D18A8E90CQ34688956-AC307FD0-B31E-43DE-B2D3-AF44BB8F4BF0Q35036742-54C3719A-62E8-438A-80EF-394FBE9FD266Q35860764-8E9076D2-BCFD-4A25-BFB1-64522546A376Q36122246-FDA3ECAE-4520-4C3D-8E71-CA54CDD081B1Q36816026-3EBBB184-3BB7-432E-806C-E8139E3FF48DQ37004918-82F47602-370E-4B72-A1F5-A62B60CB33BEQ37294006-15858E49-075A-44FB-AE8E-BC48B443B962Q37431935-11A5C631-34CA-4E0C-9D2F-82708793D854Q37452948-A021BA23-5764-46D9-BBF8-7F3D09F3B31AQ38227859-913ED352-4129-480D-B2F0-237FA91ED73DQ38948599-CF81A874-7AD6-4871-85E3-4A63D3F25491Q39330274-6BD1DDAD-937D-4393-816A-5ECA72375218Q39546545-872706D9-3FCA-4FCE-94CA-E9F820B9688EQ39683721-E4D1FD85-FEC4-410E-82DE-4BE29CA7EFBFQ40305746-D1FE5C04-B603-4E6B-BB03-6FA1C5C3D7FCQ41322931-048164C9-ECE1-4E29-80AD-E9B5EDBF2607Q41502936-E091B57F-B4D7-4DAF-9C4F-D9017BBE43A0Q41565841-98261FB8-C49E-46EE-96E5-6F14330E6550Q41789061-258827BE-1ED6-4692-8B80-BE1FF6879AD2Q42165602-3887475B-E915-4ACF-9D38-6B56B604D339Q42237511-144AB126-BED1-4848-AEBD-386F25AE0D47Q42380747-D5116744-253E-426E-8974-E68E03DCAA8AQ42843034-4F60B9D5-FF82-48C1-BF69-C0B1DF850506Q42986053-40BFED3C-4C59-4B25-8E19-AB4F8A57836DQ42994531-FA7505B0-E7D2-4ACB-8898-E54A035C5EEBQ43956692-356BD347-3B57-43A0-B0E7-39EFA4C78FC9Q43975363-A1EE9FA0-1B19-47B4-938D-1B20C6E6EB4C
P2860
A linear steady-state treatment of enzymatic chains. Critique of the crossover theorem and a general procedure to identify interaction sites with an effector.
description
1974 nî lūn-bûn
@nan
1974年の論文
@ja
1974年学术文章
@wuu
1974年学术文章
@zh
1974年学术文章
@zh-cn
1974年学术文章
@zh-hans
1974年学术文章
@zh-my
1974年学术文章
@zh-sg
1974年學術文章
@yue
1974年學術文章
@zh-hant
name
A linear steady-state treatmen ...... action sites with an effector.
@en
A linear steady-state treatmen ...... action sites with an effector.
@nl
type
label
A linear steady-state treatmen ...... action sites with an effector.
@en
A linear steady-state treatmen ...... action sites with an effector.
@nl
prefLabel
A linear steady-state treatmen ...... action sites with an effector.
@en
A linear steady-state treatmen ...... action sites with an effector.
@nl
P1433
P1476
A linear steady-state treatmen ...... action sites with an effector.
@en
P2093
R Heinrich
T A Rapoport
P304
P356
10.1111/J.1432-1033.1974.TB03319.X
P407
P577
1974-02-01T00:00:00Z